Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Published:2007-11 Issue:19 Volume:50 Page:1844-1851
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cannon Christopher P.,Husted Steen,Harrington Robert A.,Scirica Benjamin M.,Emanuelsson Håkan,Peters Gary,Storey Robert F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;N Engl J Med,2001

2. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation;Sabatine;N Engl J Med,2005

3. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

4. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE);Lancet,1996

5. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

Cited by 447 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic coronary syndromes: diagnosis, management and gaps in evidence;Heart, Vessels and Transplantation;2024-08-28

2. A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor;Frontiers in Pharmacology;2024-04-09

3. Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction;Thrombosis and Haemostasis;2024-04-04

4. Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis;Heliyon;2024-03

5. Progress in the clinical effects and adverse reactions of ticagrelor;Thrombosis Journal;2024-01-10